COVID-19 vaccines have caused a small number of deaths, primarily from rare blood clotting reactions and heart inflammation. But the scale is tiny compared to the millions of lives the vaccines saved. The best available evidence, drawn from studies tracking millions of people over multiple years, consistently shows that vaccinated individuals have lower death rates than unvaccinated individuals, not higher ones.
That said, “vaccines are safe” and “vaccines have killed some people” are both true statements. The real question is how large each risk is and how they compare. Here’s what the data actually shows.
What the Large Studies Found
A French study tracked adults aged 18 to 59 over four years and found that vaccinated individuals had a 25% lower risk of dying from any cause compared to unvaccinated individuals. That includes deaths from car accidents, cancer, heart disease, everything, not just COVID. Their risk of dying specifically from severe COVID was 74% lower. In the six months following vaccination, overall mortality dropped by 29%.
A separate U.S. study through the Vaccine Safety Datalink, covering more than 6 million vaccine recipients, looked specifically at non-COVID deaths to see if the vaccines themselves were causing fatal harm. Recipients of all three U.S. vaccines (Pfizer, Moderna, and Johnson & Johnson) had lower non-COVID mortality than unvaccinated comparison groups. After adjusting for differences between the groups, the vaccinated still had roughly half the death rate from non-COVID causes. The researchers noted some of this gap likely reflects that healthier people were more likely to get vaccinated, but even accounting for that, they found no signal of increased death risk.
Globally, a study published in JAMA estimated that COVID-19 vaccination prevented roughly 2.5 million deaths between 2020 and 2024. That works out to about one death averted for every 5,400 doses given.
Deaths That Were Linked to the Vaccines
The most clearly documented fatal side effect was a blood clotting condition called thrombosis with thrombocytopenia syndrome, or TTS. This occurred almost exclusively with the adenovirus-type vaccines (Johnson & Johnson and AstraZeneca), not the mRNA vaccines from Pfizer and Moderna. TTS struck roughly 3 out of every 100,000 people vaccinated, and among those who developed it, fatality rates ranged from 5% to 44% depending on the country and how quickly it was recognized and treated. This risk is the primary reason the Johnson & Johnson vaccine was pulled from the U.S. market and AstraZeneca was restricted or withdrawn in many countries.
Heart inflammation (myocarditis) following mRNA vaccines drew significant concern, particularly in younger men. A study in the Journal of the American College of Cardiology compared 104 patients who developed myocarditis after vaccination to 762 who developed it from viral infections. One vaccinated patient died (1.0%), compared to 84 deaths (11.0%) in the viral myocarditis group. The vaccine-associated cases had a 92% lower mortality risk after adjustment. Heart failure and other serious cardiac complications were also far less common in the post-vaccine group. Vaccine-related myocarditis, while real, tends to be milder than the kind caused by infections.
A systematic review of autopsy reports identified 28 cases worldwide (through mid-2023) where death from vaccine-induced myocarditis was considered causally linked to COVID-19 vaccination. The reviewers applied established criteria for causation and concluded the link was likely. Twenty-eight confirmed deaths is not zero, and each one matters. But against billions of doses administered globally, it represents an extraordinarily rare event.
Anaphylaxis, a severe allergic reaction, was another early concern. CDC monitoring of the first 4 million Moderna doses found 10 cases of anaphylaxis (about 2.5 per million doses), with nine occurring within 15 minutes of the shot. No anaphylaxis deaths were reported. This is why vaccination sites required a 15-minute observation period.
What the Adverse Event Reports Show
The World Health Organization’s global safety database, VigiBase, collected about 313,000 reports of adverse events following mRNA COVID-19 vaccines through February 2022. Of those, roughly 25,000 (8%) were classified as involving death. This number is frequently cited as proof of mass harm, but it requires important context.
Adverse event reporting systems collect every death that happens after vaccination, regardless of cause. If someone gets vaccinated on Monday and dies in a car crash on Thursday, that death can be reported. If an 85-year-old in a nursing home gets vaccinated and dies of heart failure three weeks later, that gets reported too. These systems are designed to cast a wide net so regulators can spot potential safety signals. They do not establish that the vaccine caused the death. When health authorities investigate these reports individually, the vast majority turn out to have other explanations.
This is why the large controlled studies comparing vaccinated and unvaccinated populations are far more informative than raw adverse event counts. If vaccines were killing people at meaningful rates, those studies would show higher mortality among the vaccinated. They consistently show the opposite.
How Vaccination Affected Community Death Rates
A CDC analysis of Oklahoma’s experience during 2020 and 2021 found that areas with higher vaccination rates had measurably lower increases in COVID death rates. During the initial rollout period of April through June 2021, each one-percentage-point increase in vaccination coverage was associated with a 6.3% relative decrease in cumulative death rates. During the Delta wave from July through December 2021, the effect was smaller (1.9% per percentage point) but still present. The pattern was clear: more vaccination, fewer deaths.
Excess mortality data from this period tells a consistent story. The spikes in deaths above normal levels tracked with COVID infection waves, not with vaccination campaigns. Countries and regions that vaccinated faster saw their excess death rates fall sooner.
The Risk in Perspective
COVID-19 vaccines carry real, documented risks. A small number of people have died from vaccine-induced blood clots or heart inflammation. For the adenovirus-type vaccines, those risks were serious enough that they were withdrawn from most markets. For the mRNA vaccines, fatal complications have been confirmed but remain extremely rare, on the order of single-digit cases per million doses.
Meanwhile, COVID-19 itself killed millions of people worldwide, with particularly high death rates among the unvaccinated during major waves. The French study’s finding bears repeating: vaccinated adults under 60 had a 74% lower risk of dying from severe COVID over four years of follow-up. The global estimate of 2.5 million deaths prevented puts the scale of benefit in stark terms.
No vaccine in history has been completely free of serious side effects. What distinguishes COVID-19 vaccines is the unprecedented scale of monitoring they received, with billions of doses tracked across multiple independent safety systems in dozens of countries. That monitoring caught the rare fatal risks, led to the withdrawal of the higher-risk vaccines, and continues to generate data. The overall picture from that data is consistent: for the vast majority of people, the vaccines reduced the risk of death rather than increasing it.